financetom
Business
financetom
/
Business
/
Urban Outfitters Insider Sold Shares Worth $5,807,048, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Urban Outfitters Insider Sold Shares Worth $5,807,048, According to a Recent SEC Filing
Jun 2, 2025 3:21 PM

06:02 PM EDT, 06/02/2025 (MT Newswires) -- Margaret Hayne, Director, Co-President & Chief Creative Officer, on May 29, 2025, sold 80,000 shares in Urban Outfitters ( URBN ) for $5,807,048. Following the Form 4 filing with the SEC, Hayne has control over a total of 24,418,806 common shares of the company, with 1,176,273 shares held directly and 23,242,533 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/912615/000095017025080425/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
The Lion Electric Q2 Net Loss Widens, Unveils Plan to Streamline Operations Including Workforce Reduction
The Lion Electric Q2 Net Loss Widens, Unveils Plan to Streamline Operations Including Workforce Reduction
Jul 31, 2024
07:03 AM EDT, 07/31/2024 (MT Newswires) -- The Lion Electric ( LEV ) , a manufacturer of all-electric medium and heavy-duty urban vehicles, on Wednesday said its second-quarter net loss widened. The net loss was US$19.3 million, or US$0.09 per share, widening from a loss of US$11.8 million, or US$0.05 per share. Revenue fell to US$30.3 million from US$58.0 million....
Teva Pharma lifts annual profit view on strong generic, Huntington's disease drug sales
Teva Pharma lifts annual profit view on strong generic, Huntington's disease drug sales
Jul 31, 2024
July 31 (Reuters) - Teva Pharmaceutical Industries raised its full-year profit forecast on Wednesday, banking on strength in its generic drug business and strong sales of its Huntington's disease drug. Teva now expects its profit for the full year 2024 to be between $2.30 and $2.50 per share, compared with its previous expectation of $2.20-$2.50 per share. ...
Persistent competition likely to keep pressure on PayPal, analysts say
Persistent competition likely to keep pressure on PayPal, analysts say
Jul 31, 2024
(Reuters) - As PayPal embarks on an ambitious turnaround strategy to revitalize growth after a post-pandemic slump, Wall Street analysts expressed some caution over competition from big-tech and beyond. The concerns highlight the challenges to the profit margins of the company, which for years enjoyed the first-mover advantage in the digital payments industry but has ceded market share more recently...
Trane Tech raises profit and revenue forecasts on resilient demand
Trane Tech raises profit and revenue forecasts on resilient demand
Jul 31, 2024
July 31 (Reuters) - Trane Technologies ( TT ) on Wednesday raised its full-year profit and revenue forecasts, anticipating strong demand for heating and air-conditioning systems from commercial buildings. Shares of the company were up 3.8% in premarket trade. The company now expects 2024 adjusted profit of $10.80 per share, above its previous forecast of between $10.40 and $10.50 per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved